Logotype for Atlas Arteria Limited

Atlas Arteria (ALX) H2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Atlas Arteria Limited

H2 2024 earnings summary

31 Mar, 2026

Executive summary

  • Net profit after tax rose 7.4% to $275.3m for 2024, driven by toll revenue growth and operational improvements.

  • Proportional toll revenue increased 5.1% year-over-year to $1,838.7m, with proportional EBITDA up 0.4% to $1,381.1m.

  • Operating free cash flow per security grew 16% to 36.3 cps, supporting a reaffirmed distribution of 40 cps.

  • Distribution guidance of AUD 0.40 per security for 2025, with a new policy to pay 90%-110% of free cash flow, aiming for clarity and certainty for investors.

  • Strategic priorities include optimizing performance, enhancing partnerships, efficient capital management, and advancing ESG and diversity targets.

Financial highlights

  • Proportional toll revenue up 5.1% year-over-year to $1,838.7m, mainly from toll increases and steady traffic.

  • Proportional EBITDA up 0.4% year-over-year to $1,381.1m, impacted by the French TILD/TEILD tax.

  • Net profit after tax increased 7.4% to $275.3m compared to 2023.

  • Operating free cash flow per security was 36.3 cps, up 16% from 2023.

  • Total revenue grew 9%, driven by Dulles Greenway, Warnow Tunnel, and FX tailwinds.

Outlook and guidance

  • Distribution guidance of AUD 0.40 per security for 2025, with a target of at least AUD 0.40 for future years.

  • 2025 distribution expected to be above policy range due to a temporary French tax; future distributions to align with policy as tax impact subsides.

  • Corporate cost guidance for 2025 is AUD 29-31 million, excluding CEO transition costs.

  • Focus on unlocking Dulles Greenway cash flow, progressing French growth, and optimizing capital management.

  • Long-term opportunities include strategic partnerships and value-accretive growth across the portfolio.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more